Design Therapeutics DSGN Cash Flow Statement (2020-2026)

NASDAQ DSGN
$12.62 +0.26 (+2.10%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Design Therapeutics Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Design Therapeutics reported cash from operations of -$15.52M and free cash flow of -$15.54M for the quarter ended Jun 2026, down 7.5% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-11.34M-11.13M-13.37M-15.64M-19.19M-19.39M-21.65M-22.60M-18.82M-15.12M-11.11M-11.79M-13.04M-13.65M-17.71M-19.08M-17.00M-16.00M-17.64M-20.16M
Depreciation and Depletion
0.03M0.08M0.08M0.09M0.11M0.12M0.13M0.13M0.14M0.14M0.14M0.15M0.15M0.15M0.16M0.15M0.15M0.16M0.16M0.15M
Share-based Compensation
1.24M1.56M2.36M2.62M2.87M3.08M3.43M3.72M3.22M2.72M3.18M3.30M3.12M3.47M3.54M3.98M3.59M3.44M3.92M3.87M
Cash from Operations
-8.16M-9.23M-11.83M-10.50M-13.90M-15.09M-17.42M-13.80M-14.53M-12.80M-12.44M-11.26M-9.55M-9.86M-16.79M-14.44M-11.16M-11.97M-16.43M-15.52M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.03M0.08M0.08M0.09M0.11M0.12M0.13M0.13M0.14M0.14M0.14M0.15M0.15M0.15M0.16M0.15M0.15M0.16M0.16M0.15M
Change in Working Capital
Change in Accured Expenses
1.37M-0.03M0.21M1.60M3.16M0.42M-1.75M3.07M0.24M-2.81M-2.52M-0.72M1.02M1.01M-0.30M0.54M2.40M1.84M-2.51M0.95M
Other Working Capital Changes
-0.47M-0.14M1.24M-0.22M1.90M0.47M-1.19M-0.60M0.64M-0.82M0.41M0.63M-0.66M-0.60M1.41M-0.45M-0.46M0.88M0.29M0.39M
Investing Activities
Capital Expenditures
0.97M0.35M0.08M0.24M0.31M0.29M0.09M0.09M0.05M0.03M0.20M0.16M-0.02M0.07M0.09M0.03M0.02M
Cash from Investing Activities
-5.04M-50.06M0.41M-156.96M-63.39M-1.06M19.73M11.98M15.27M5.55M20.62M27.33M-5.83M1.83M7.87M20.12M6.51M-11.58M-7.59M15.06M
Financing Activities
Change in Capital Stock
Net Equity Issued and Repurchased
0.16M0.15M0.02M0.01M0.40M0.02M0.01M0.00M0.01M0.02M0.04M24.79M19.91M
Misc.
Cash from Financing Activities
0.03M0.19M0.16M-0.20M0.15M0.13M0.01M0.50M0.02M0.23M0.00M0.26M0.02M0.36M0.04M25.32M19.93M0.60M
Change in Cash
-13.18M-59.09M-11.26M-167.66M-77.14M-16.02M2.31M-1.61M0.74M-6.74M8.20M16.30M-15.37M-7.76M-8.90M6.04M-4.62M1.77M-4.09M0.14M
Free Cash Flow
-9.13M-9.58M-11.90M-10.74M-14.21M-15.38M-17.51M-13.89M-14.59M-12.82M-12.63M-11.42M-9.53M-9.86M-16.86M-14.53M-11.16M-12.00M-16.43M-15.54M
Net Cash Flow
-13.18M-59.09M-11.26M-167.66M-77.14M-16.02M2.31M-1.82M0.74M-6.74M8.20M16.30M-15.37M-7.76M-8.90M6.04M-4.62M1.77M-4.09M0.14M

Design Therapeutics Cash Flow Statement API

Pull Design Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DSGN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY